This dual-peptide formulation combines BPC-157, a synthetic peptide fragment derived from a naturally occurring gastric protein, with TB-500, a stabilized analogue of the active region of Thymosin Beta-4. Together, these research compounds provide a complementary platform for investigating cellular migration, angiogenic signaling, and cytoskeletal dynamics. Their distinct yet synergistic mechanisms make this combination well suited for advanced in vitro and preclinical research focused on tissue-level interactions and regenerative biological pathways.

WHY IT STANDS OUT

Combines two complementary research peptides in a single formulation
Supports research involving tissue remodeling, cellular migration, and structural repair mechanisms
Associated with angiogenic signaling and cytoskeletal organization in preclinical studies
Broad research applications across muscle, tendon, ligament, and connective tissue models

⸻

PRODUCT SPECIFICATIONS

MOLECULAR FORMULA
BPC-157: C₆₂H₉₈N₁₆O₂₂
TB-500 (Thymosin Beta-4 Fragment): C₂₁₂H₃₅₀N₅₆O₇₈S

MOLECULAR WEIGHT
BPC-157: 1419.53 g/mol
TB-500: 4963.44 g/mol

PURITY
≥99% (Each Component)

CONTENTS

10 mg BPC-157
10 mg TB-500

⸻

SEQUENCE

BPC-157
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

TB-500 (TB-4 Fragment)
Ac-Lys-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH